HighTower Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

HighTower Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,763	Closed	-$899K	–	2347
2018 Q3	$899K	Buy	22,763 +7,065	+45%	+$268K	0.01%	1177
2018 Q2	$586K	Buy	15,698 +1,375	+10%	+$49.9K	﹤0.01%	1375
2018 Q1	$488K	Buy	14,323 +5,575	+64%	+$195K	﹤0.01%	1423
2017 Q4	$285K	Buy	+8,748	New	+$274K	﹤0.01%	1733

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFG

Bouchey Financial Group Troy, New York $1.36B AUM 13.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HighTower Advisors's SBIO Position: Q4 2018 in Review

HighTower Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2018, closing a stake of 22,763 shares — an estimated $899K sold.

HighTower Advisors first reported a position in SBIO in Q4 2017 and held it in 4 quarters. The position peaked at $899K in Q3 2018. 48 funds tracked by Wall St. Rank hold SBIO as of Q4 2018.

HighTower Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2018 after selling out during the quarter.
HighTower Advisors sold 22,763 ALPS Medical Breakthroughs ETF shares in Q4 2018, an estimated $899K.
HighTower Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2017 and held it in 4 quarters.
HighTower Advisors's ALPS Medical Breakthroughs ETF position peaked at $899K in Q3 2018.
48 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2018.

Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.